Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (211-220 of 666) with videos related to

Pageof 67
Sort By:
Future Oncology (London, England)|April 29, 2026
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapyRana R McKay, Nasreen Khan, Neal D Shore, et al.
Urologic Oncology|July 29, 2019
Corrigendum to: National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancerAdam B Weiner, Oliver S Ko, Alec Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2021
Reporting of Racial Health Disparities Research: Are We Making Progress?Randy A Vince, Nicholas W Eyrich, Brandon A Mahal, et al.
Cancer Epidemiology|September 25, 2010
Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian populationNathan R Jones, Thomas E Spratt, Arthur S Berg, et al.
Nature Reviews. Urology|August 7, 2021
Salvage therapy for prostate cancer after radical prostatectomyNicholas G Zaorsky, Jeremie Calais, Stefano Fanti, et al.
Chemical Research in Toxicology|May 1, 1997
Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferaseL Wang, T E Spratt, X K Liu, et al.
The Journal of Urology|February 8, 2019
Bringing Prostate Cancer Germline Genetics into Clinical PracticeSanjay Das, Simpa S Salami, Daniel E Spratt, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Utility of ERG Immunohistochemistry for Evaluation of Lymphovascular Invasion in Testicular Germ Cell Tumors: A Retrospective Pilot StudyAaron M Udager, Jonathan B McHugh, Todd M Morgan, et al.
Journal of Clinical Psychopharmacology|February 25, 2011
Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathyWei Jiang, Shelby Ladd, Carolyn Martsberger, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Effect of the Maximum Dose on White Matter Fiber Bundles Using Longitudinal Diffusion Tensor ImagingTong Zhu, Christopher H Chapman, Christina Tsien, et al.
Pageof 67

Showing results (211-220 of 666) with videos related to

Sort By:
Pageof 67
Future Oncology (London, England)|April 29, 2026
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapyRana R McKay, Nasreen Khan, Neal D Shore, et al.
Urologic Oncology|July 29, 2019
Corrigendum to: National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancerAdam B Weiner, Oliver S Ko, Alec Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2021
Reporting of Racial Health Disparities Research: Are We Making Progress?Randy A Vince, Nicholas W Eyrich, Brandon A Mahal, et al.
Cancer Epidemiology|September 25, 2010
Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian populationNathan R Jones, Thomas E Spratt, Arthur S Berg, et al.
Nature Reviews. Urology|August 7, 2021
Salvage therapy for prostate cancer after radical prostatectomyNicholas G Zaorsky, Jeremie Calais, Stefano Fanti, et al.
Chemical Research in Toxicology|May 1, 1997
Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferaseL Wang, T E Spratt, X K Liu, et al.
The Journal of Urology|February 8, 2019
Bringing Prostate Cancer Germline Genetics into Clinical PracticeSanjay Das, Simpa S Salami, Daniel E Spratt, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Utility of ERG Immunohistochemistry for Evaluation of Lymphovascular Invasion in Testicular Germ Cell Tumors: A Retrospective Pilot StudyAaron M Udager, Jonathan B McHugh, Todd M Morgan, et al.
Journal of Clinical Psychopharmacology|February 25, 2011
Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathyWei Jiang, Shelby Ladd, Carolyn Martsberger, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Effect of the Maximum Dose on White Matter Fiber Bundles Using Longitudinal Diffusion Tensor ImagingTong Zhu, Christopher H Chapman, Christina Tsien, et al.
Pageof 67